Phio Pharmaceuticals Corp.
PHIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $10,705 | $10,775 | $13,278 | $5,382 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $788 | $519 | $158 | $354 |
| Total Curr. Assets | $11,493 | $11,294 | $13,436 | $5,736 |
| Property Plant & Equip (Net) | $12 | $7 | $4 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $12 | $7 | $4 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $11,505 | $11,301 | $13,440 | $5,738 |
| Liabilities | – | – | – | – |
| Payables | $516 | $235 | $427 | $253 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $971 | $843 | $762 |
| Total Curr. Liab. | $516 | $1,206 | $1,270 | $1,015 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1,150 | $0 | $0 | $0 |
| Total NC Liab. | $1,150 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,666 | $1,206 | $1,270 | $1,015 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $0 | $0 | $0 |
| Retained Earnings | -$152,683 | -$150,291 | -$148,125 | -$146,356 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $162,521 | $160,386 | $160,295 | $151,079 |
| Total Equity | $9,839 | $10,095 | $12,170 | $4,723 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $11,505 | $11,301 | $13,440 | $5,738 |
| Net Debt | -$10,705 | -$10,775 | -$13,278 | -$5,382 |